Amvex Biopharmaceuticals

Amvax is a biotechnology company based in San Diego, California, focused on the development of a new generation of vaccines for the treatment of cancer and infectious diseases. The company's core technology centers on telomerase-based vaccines, specifically targeting the telomerase reverse transcriptase (TERT) enzyme, which is overexpressed in the majority of human cancers. By leveraging novel immunological approaches, Amvax aims to stimulate robust T-cell responses to eliminate malignant cells while sparing healthy tissue. The company's research is rooted in academic collaborations and aims to address significant unmet needs in oncology through precision immunotherapy.